| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 06/22/2006 | US20060134538 Aromatic chalcogen compounds and their use |
| 06/22/2006 | DE102004061593A1 Substituierte N-heterocyclische Verbindungen und ihre therapeutische Verwendung Substituted N-heterocyclic compounds and their therapeutic use |
| 06/22/2006 | DE102004061008A1 3-Arylalkyl- und 3-Heteroarylalkyl-substituierte 1,2,4-Triazin-5(2H)-one 3-arylalkyl and heteroarylalkyl 3-substituted-1,2,4-triazine-5 (2H) -ones |
| 06/22/2006 | CA2592353A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 06/22/2006 | CA2591621A1 Enantiomers of 3-heteroaryl-8h-8-azabicyclo(3.2.1)oct-2-ene and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/22/2006 | CA2591413A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases |
| 06/22/2006 | CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | CA2591033A1 Heterocyclic aspartyl protease inhibitors |
| 06/22/2006 | CA2589793A1 4-(4-(imidazol-4-yl)pyrimidin-2-ylamino) benzamides as cdk inhibitors |
| 06/22/2006 | CA2589501A1 Indolinones and their use as antiproliferative agents |
| 06/22/2006 | CA2588384A1 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 06/22/2006 | CA2587423A1 1-arylpyrazoles and their use as pesticides |
| 06/21/2006 | EP1671968A1 Process for obtaining enantiomers of thienylazolylalcoxyethanamines |
| 06/21/2006 | EP1671967A1 1-Arylpyrazoles and their use as pesticides |
| 06/21/2006 | EP1671966A1 Cephem compounds and pharmaceutical compositions containing the same |
| 06/21/2006 | EP1670804A2 Heterobicyclic compounds as pharmaceutically active agents |
| 06/21/2006 | EP1670791A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 06/21/2006 | EP1670790A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 06/21/2006 | EP1670786A1 Quinazoline derivatives |
| 06/21/2006 | EP1670783A2 Antithrombotic aromatic ethers |
| 06/21/2006 | EP1670758A1 Substituted indole acid derivatives and their use as pai-1 inhibitors |
| 06/21/2006 | EP1670757A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 06/21/2006 | EP1670739A2 Cyclic diamines and derivatives as factor xa inhibitors |
| 06/21/2006 | EP1670473A1 Substituted quinolines as protein tyrosine kinase enzyme inhibitors |
| 06/21/2006 | EP1670470A1 Pyridine derivatives and use thereof as urotensin ii antagonists |
| 06/21/2006 | EP1670460A2 Pyrazole derivatives as cannabinoid receptor modulators |
| 06/21/2006 | EP1341779B1 Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 06/21/2006 | EP1286985B1 Substituted pyridine herbicides |
| 06/21/2006 | EP1268419B1 Pyrrolidine derivatives useful as bax inhibitors |
| 06/21/2006 | EP1255734B1 Isatine derivatives with neurotrophic activity |
| 06/21/2006 | EP0920316B1 Treatment of manic disorders |
| 06/21/2006 | EP0815100B1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 06/21/2006 | CN1791598A Benzimidazole-derivatives as factor Xa inhibitors |
| 06/21/2006 | CN1791591A Bioreductively-activated prodrugs |
| 06/21/2006 | CN1791581A Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors |
| 06/21/2006 | CN1791578A Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists |
| 06/21/2006 | CN1791576A Benzamide modulators of metabotropic glutamate receptors |
| 06/21/2006 | CN1791575A Cyanofluoropyrrolidine derivative. |
| 06/21/2006 | CN1791410A Methods for treating or preventing an inflammatory or metabolic condition by inhibiting JNK |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1260222C Antagonists of mcp-1 function and methods of use thereof |
| 06/20/2006 | US7064218 Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity |
| 06/20/2006 | US7064207 Androgen receptor antagonists |
| 06/20/2006 | US7064201 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 06/20/2006 | US7064144 Imidazole derivatives as adenosine deaminase inhibitors |
| 06/20/2006 | US7064137 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 06/20/2006 | US7064135 Antihistamines; anticholesterol agents; cardiovascular disorders; antidiabetic agents; anticancer agents |
| 06/20/2006 | US7064122 Pancreatic lipase inhibitor compounds, their synthesis and use |
| 06/15/2006 | WO2006062982A2 Urea inhibitors of map kinases |
| 06/15/2006 | WO2006062890A1 Method of making imidazole-2-thiones |
| 06/15/2006 | WO2006062247A1 Substituted heterocyclic compound and thrombopoietin receptor activator |
| 06/15/2006 | WO2006062093A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | WO2006061585A1 Pyrrolidine compounds |
| 06/15/2006 | WO2006034822A8 Novel substituted thiophencarboxylic acid amides, production thereof and use thereof as medicaments |
| 06/15/2006 | WO2006015860A3 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
| 06/15/2006 | WO2005122698A3 Novel stable polymorphic forms of tiagabine hydrochloride |
| 06/15/2006 | WO2005058843A8 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/15/2006 | US20060128961 Process for the production of meso-substituted cyanine dyes |
| 06/15/2006 | US20060128783 Tyrosine kinase inhibitors |
| 06/15/2006 | US20060128750 Targeting chemokine receptors and interfere with the binding of the natural ligand thereto; antagonists or agonists; protecting target cells from HIV infection; treating HIV or FIV infected patients |
| 06/15/2006 | US20060128747 To treat Gram-positive bacterial infections; antibacterial and/or antifungal properties; Preferably drug-resistant strains of bacteria |
| 06/15/2006 | US20060128737 Androgen receptor agonists |
| 06/15/2006 | US20060128735 Substituted thiophenes with antibacterial activity |
| 06/15/2006 | US20060128723 Sulptionamide compounds that modulate chemokine receptor activity (CCR4) |
| 06/15/2006 | US20060128722 Indoles useful in the treatment of androgen-receptor related diseases |
| 06/15/2006 | US20060128684 Anthranilic acid amide derivatives and their pharmaceutical use |
| 06/15/2006 | US20060128642 Pesticides, controlling animal pests |
| 06/15/2006 | US20060128635 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 06/15/2006 | US20060124049 Crystalline form |
| 06/15/2006 | CA2588633A1 Novel anthranilic acid derivative or salt thereof |
| 06/14/2006 | EP1669348A1 Novel antifungal agent comprising heterocyclic compound |
| 06/14/2006 | EP1669345A1 Ester derivative and medicinal use thereof |
| 06/14/2006 | EP1669069A1 Compounds effecting glukokinase |
| 06/14/2006 | EP1669068A1 Compounds effecting Glucokinase |
| 06/14/2006 | EP1668669A2 Material and cell structure for memory applications |
| 06/14/2006 | EP1668007A1 Dioxolane derivatives as cell adhesion inhibitors |
| 06/14/2006 | EP1668006A1 Quinazoline derivatives as antiproliferative agents |
| 06/14/2006 | EP1668002A2 2,4-dioxo-3-quinazolinylaryl sulfonylureas |
| 06/14/2006 | EP1668000A1 Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists |
| 06/14/2006 | EP1667993A1 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 06/14/2006 | EP1667990A2 New compounds |
| 06/14/2006 | EP1667989A1 Substituted isoquinolinones |
| 06/14/2006 | EP1667984A1 Gamma-secretase inhibitors |
| 06/14/2006 | EP1667981A1 Isoquinoline potassium channel inhibitors |
| 06/14/2006 | EP1667980A1 1,4-disubstituted isoquinoline derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases |
| 06/14/2006 | EP1667970A1 Heterocyclic- or aryloxy, -thio 0r -amino substituted indoles-2-carboxylic acids or esters as pai-1 inhibitors |
| 06/14/2006 | EP1667647A2 Monocyclic and bicyclic lactams as factor xa inhibitors |
| 06/14/2006 | EP1667635A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 06/14/2006 | EP1506190B1 (imidazol-1-yl-methyl)-pyridazine as nmda receptor blocker |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1339683B1 Estrogen receptor modulators |
| 06/14/2006 | EP1309564B1 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 06/14/2006 | EP1268418B1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 06/14/2006 | CN1788007A Crystal of benzimidazole derivative and process for producing the same |
| 06/14/2006 | CN1788006A Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 06/14/2006 | CN1788000A Phthalazinone derivatives |
| 06/14/2006 | CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 06/14/2006 | CN1785996A Antifungus compound, its preparation method and application |
| 06/14/2006 | CN1259316C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 06/14/2006 | CN1259315C Antagonists of MCP-1 function and methods of use thereof |